Hematologic Complications of Immune Checkpoint Inhibitors.

Davis EJ, Salem JE, Young A, Green JR, Ferrell PB, Ancell KK, Lebrun-Vignes B, Moslehi JJ, Johnson DB
Oncologist. 2019 24 (5): 584-588

PMID: 30819785 · PMCID: PMC6516131 · DOI:10.1634/theoncologist.2018-0574

MeSH Terms (19)

Adult Adverse Drug Reaction Reporting Systems Aged Aged, 80 and over Antibodies, Monoclonal, Humanized Antineoplastic Agents, Immunological B7-H1 Antigen Databases, Factual Female Hematologic Diseases Humans Incidence Ipilimumab Male Middle Aged Neoplasms Pharmacovigilance Programmed Cell Death 1 Receptor Risk Factors

Connections (1)

This publication is referenced by other Labnodes entities: